Pediatric Oncology

The OncLive Pediatric Oncology condition center page is a comprehensive resource for clinical news and expert insights on various types of cancers in pediatric patients, including acute lymphoblastic leukemia, acute myeloid leukemia, brain cancers, sarcomas, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in childhood and adolescent and young adult cancers.

Latest News

FDA
FDA Approves Mirdametinib for NF1-Associated Plexiform Neurofibromas

February 11th 2025

The FDA has approved mirdametinib for patients with neurofibromatosis type 1 who have symptomatic plexiform neurofibromas.

Here is your snapshot of all therapeutic options that were approved by the FDA in January 2025 spanning tumor types.
OncLive’s FDA Approval Report: The Regulatory Rundown for January 2025

February 3rd 2025

FDA
FDA Approves Treosulfan for alloHCT Conditioning in AML and MDS

January 24th 2025

FDA
FDA Approves Remestemcel-L for Pediatric Steroid-Refractory Acute Graft-vs-Host Disease

December 18th 2024

Pediatric B-ALL
Bicistronic CD19/CD22-Directed CAR T-Cell Therapy Is Safe, Elicits Durable Responses in Pediatric R/R B-ALL

December 7th 2024

Video Series
Video Interviews
Podcasts

More News